Endo International competitors and similar companiesClear all

Endo International's competitors and similar companies include Hikma Pharmaceuticals, Teva, Takeda and KRKA.

	Endo International Endo International plc is global specialty healthcare company. It was created as a result of a management buyout from DuPont Merck in 1997.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	Teva Teva is a pharmaceuticals company.	Takeda Takeda is a biopharmaceutical company that provides healthcare solutions.	KRKA KRKA is an international generic pharmaceutical company.
Founding Date	Founding Date 1997	Founding Date 1978	Founding Date 1901	Founding Date 1995	Founding Date 1954
Type	Type Public	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Dublin 4, IE HQ Ciudad De México, MX Midrand, ZA Watford, GB Charlotte, US Charlotte, US Chestnut Ridge, US see more	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations HQ	Locations Opfikon, CH HQ Chuo City, JP Fujisawa, JP Hikari, JP Kyoto, JP Osaka, JP Osaka, JP	Locations SI HQ
Employees	Employees 3,1729% increase	Employees 8,700	Employees 25,286	Employees 34,826	Employees 11,6181% increase
Valuation ($)	Valuation ($) 68.4 m	Valuation ($) 4.8 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Twitter followers	Twitter followers 939	Twitter followers 2.6 k	Twitter followers 5.2 k	Twitter followers 28.4 k	Twitter followers N/A
Alexa Website Rank	Alexa Website Rank 372460	Alexa Website Rank 230430	Alexa Website Rank 626179	Alexa Website Rank N/A	Alexa Website Rank 231469
Employee Rating	Employee Rating 3.8	Employee Rating 3.7	Employee Rating N/A	Employee Rating N/A	Employee Rating 3
Financial
Revenue (est.)	Revenue (est.) $3b (FY, 2021)	Revenue (est.) $2.6b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €1.6b (FY, 2021)
Cost of goods	Cost of goods $6.2m (FY, 2021)	Cost of goods $1.1b (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods €565.8m (FY, 2021)
Gross profit	Gross profit $3b (FY, 2021)	Gross profit $1.5b (FY, 2021)	Gross profit N/A	Gross profit N/A	Gross profit €1b (FY, 2021)
Net income	Net income ($569.1m) (FY, 2021)	Net income $420m (FY, 2021)	Net income N/A	Net income N/A	Net income €308.2m (FY, 2021)